Body

Motor protein may offer promise in ovarian cancer treatment

A motor regulatory protein can block human ovarian tumor growth, leading to eventual cancer cell death and possible new therapies to treat the disease, according to Penn State College of Medicine researchers.

Among U.S. women, an estimated 21,880 new cases and 13,850 deaths occurred in 2010 from epithelial ovarian cancer, one of the most common forms of ovarian cancer and the most lethal gynecologic cancer in women.

Chernobyl's radioactivity reduced the populations of birds of orange plumage

On April 26, 1986, history's greatest nuclear accident took place northwest of the Ukrainian city of Chernobyl. Despite the scale of the disaster, 25 years later, we still do not know its real effects. An international team of investigators has shown for the first time that the colour of birds' plumage may make them more vulnerable to radioactivity.

Radiation causes oxidative stress, damages biological molecules and may have "important" negative effects on organisms in relatively high doses, like those found in certain zones close to Chernobyl.

Topical treatment may prevent melanoma

While incidents of melanoma continue to increase despite the use of sunscreen and skin screenings, a topical compound called ISC-4 may prevent melanoma lesion formation, according to Penn State College of Medicine researchers.

"The steady increase in melanoma incidence suggests that additional preventive approaches are needed to complement these existing strategies," said Gavin Robertson, Ph.D., professor of pharmacology, pathology, dermatology and surgery, and director of Penn State Hershey Melanoma Center.

Racial differences in willingness to exhaust personal finances for life-sustaining care

Minority races—especially Blacks—are more willing than Whites to expend personal financial resources to prolong life after being diagnosed with lung or colorectal cancer, even if it means using up all of their personal financial resources. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. Delivering quality cancer care that is in accordance with patients' wishes requires a better understanding of the reasons for these differences in preference.

Study finds flame retardants at high levels in pet dogs

BLOOMINGTON, Ind. -- Indiana University scientists have found chemical flame retardants in the blood of pet dogs at concentrations five to 10 times higher than in humans, but lower than levels found in a previous study of cats.

Their study, "Flame Retardants in the Serum of Pet Dogs and in their Food," appears this month in the journal Environmental Science & Technology. Authors are Marta Venier, an assistant research scientist in the School of Public and Environmental Affairs, and Ronald Hites, a Distinguished Professor in SPEA.

Blacks more willing to exhaust financial resources for more cancer care

BIRMINGHAM, Ala. – People in minority groups, especially black Americans, are more willing than their white counterparts to exhaust their personal financial resources to prolong life after being diagnosed with lung or colorectal cancer, according to a University of Alabama at Birmingham study published April 26, 2011, online in Cancer, the journal of the American Cancer Society.

Gynecologic cancer expert helps pinpoint best treatment for fast-growing gestational tumors

DALLAS – April 26, 2011 – A clinical trial has sifted out the most effective single-drug chemotherapy regimen for quick-growing but highly curable cancers that arise from the placentas of pregnant women.

In the comparison trial for treating low-risk gestational trophoblastic neoplasia (GTN), researchers found that a biweekly dose of dactinomycin had a higher complete response rate than a weekly dose of methotrexate, the more commonly used drug. GTN is a group of rare tumors that involve abnormal growth of cells inside a woman's uterus.

Antibiotic may prove beneficial to preterm infant lung health

LEXINGTON, Ky. (April 26, 2011) – A study performed by University of Kentucky researchers shows promise for the use of azithromycin in treating Ureaplasma-colonized or infected premature infants to prevent bronchopulmonary dysplasia (BPD).

The study, published in Pediatric Pulmonology, showed subjects colonized or infected with the Ureaplasma bacteria developed BPD or died 73 percent of the time in the azithromycin-treated group, compared to 94 percent of the time in the placebo group.

New study sheds light on evolution of 2009 pandemic influenza A(H1N1) virus in Japan

Analysis of mutations of the 2009 pandemic influenza A(H1N1) virus by researchers at the RIKEN Omics Science Center (OSC) has revealed major genetic differences between the virus in its early phase of infection in Japan and in its peak phase. While yielding valuable clues on the genetic origins of drug resistance, the findings also pave the way toward the development of new diagnostic kits for detecting and preventing the spread of global pandemic diseases.

University of Oklahoma researchers working to advance predictability research initiatives

NORMAN, Okla. – Faculty from the University of Oklahoma School of Meteorology are leading the school's predictability research initiatives with multiple projects that could one day lead to more accurate forecasts of weather-related events, including landslides and tornadoes.

In the Southern Plains region of the United States, people think of thunderstorms and tornadoes when severe weather is forecasted. However, the OU School of Meteorology is interested in a broad range of weather phenomena and its impacts.

Death rates among those with high blood pressure decreasing, but still high

Death rates have decreased among people with high blood pressure but remain far higher than in those without it, according to research in Circulation: Journal of the American Heart Association.

Targeted agent selumetinib shows promise in biliary cancer

COLUMBUS, Ohio – The experimental agent selumetinib has shown promising results in people with advanced biliary cancer, according to a multi-institutional clinical trial led by cancer researchers at The Ohio State University.

Selumetinib, also known as AZD6244 (ARRY-142886), blocks a protein called MEK, which cancer cells need to proliferate and survive.

Tai chi appears to benefit quality of life for patients with chronic heart failure

Tai chi exercise appears to be associated with improved quality of life, mood and exercise self-efficacy in patients with chronic heart failure, according to a report in the April 25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Study examines changes in medical students’ views about internal medicine careers

Compared with 1990, more medical students in 2007 viewed internal medicine as a potentially meaningful career; however, the majority of students are choosing other specialties, according to a report in the April 25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

HIV infection may be a risk factor for heart failure

Patients with HIV infection without a prior history of coronary heart disease may be at a higher risk of developing heart failure, according to a report in the April 25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.